Pasithea Therapeutics Announces Pricing of $5 Million Public Offering
Seeking Alpha / 26 minutes from now 2 Views
Pasithea Therapeutics (Nasdaq: KTTA) prices $5M public offering to fund clinical trials, R&D, and corporate initiatives; closing expected May 7, 2025.
Comments